784 results on '"Farmer, Cristan"'
Search Results
2. Spindle chirp and other sleep oscillatory features in young children with autism
3. GM1 gangliosidosis type II: Results of a 10-year prospective study
4. NIH Toolbox Cognition Battery Feasibility in Individuals with Williams Syndrome
5. Making Research Possible: Barriers and Solutions for Those with ASD and ID
6. Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study
7. Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives
8. Corrigendum: Bias in measurement of autism symptoms by spoken language level and non-verbal mental age in minimally verbal children with neurodevelopmental disorders
9. Bias in measurement of autism symptoms by spoken language level and non-verbal mental age in minimally verbal children with neurodevelopmental disorders
10. Patterns of delay in early gross motor and expressive language milestone attainment in probands with genetic conditions versus idiopathic ASD from SFARI registries
11. Age of walking and intellectual ability in autism spectrum disorder and other neurodevelopmental disorders: a population‐based study
12. Extracting Latent Subdimensions of Social Communication: A Cross-Measure Factor Analysis
13. Cerebrospinal fluid exploratory proteomics and ketamine metabolite pharmacokinetics in human volunteers after ketamine infusion
14. Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency
15. Sex differences in scores on standardized measures of autism symptoms: a multisite integrative data analysis.
16. Making Research Possible: Barriers and Solutions For Those With ASD and ID
17. Dr. Bishop et al. Reply
18. Posterior superior temporal cortex connectivity is related to social communication in toddlers
19. Evaluating the Effectiveness of Psychotropic Medications: Principles, Experimental Designs, and Outcome Measures
20. The Need for a Developmentally Based Measure of Social Communication Skills
21. Functional brain connectivity in electrical status epilepticus in sleep
22. State of the Field: Differentiating Intellectual Disability From Autism Spectrum Disorder
23. Cerebrospinal fluid vasopressin and symptom severity in children with autism
24. The relationship between the HDRS insomnia items and polysomnographic (PSG) measures in individuals with treatment-resistant depression
25. Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders
26. Comparative metabolomic analysis in plasma and cerebrospinal fluid of humans and in plasma and brain of mice following antidepressant-dose ketamine administration
27. Leiter International Performance Scale-Revised (Leiter-R)
28. Aberrant Behavior Checklist
29. Evaluating the Effectiveness of Psychotropic Medications: Principles, Experimental Designs, and Outcome Measures
30. Psychometric perspectives on developmental outcome and endpoint selection in treatment trials for genetic conditions associated with neurodevelopmental disorder
31. Differences in Sleep EEG Coherence and Spindle Metrics in Toddlers With and Without Language Delay: A Prospective Observational Study
32. Intravenous delivery of AAV9-GLB1 gene therapy for GM1 gangliosidosis: An interim analysis
33. GM1 Gangliosidosis Type II: Results of a 10-Year Prospective Study
34. Inclusion of individuals with low IQ in drug development for autism spectrum disorder
35. The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
36. Identification of Developmental and Behavioral Markers Associated With Genetic Abnormalities in Autism Spectrum Disorder
37. Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation
38. Talking about Death or Suicide: Prevalence and Clinical Correlates in Youth with Autism Spectrum Disorder in the Psychiatric Inpatient Setting
39. Attainment and loss of early social‐communication skills across neurodevelopmental conditions in the Norwegian Mother, Father and Child Cohort Study.
40. Measurement Invariance in Intellectual and Developmental Disability Research.
41. Effective Medications for Treating Individuals with Autism Spectrum Disorder
42. Utilization of the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure-Adult to Screen Healthy Volunteers for Research Studies
43. Cortical thickness change in autism during early childhood
44. Autism Spectrum Disorder, Intellectual Disability, and Delayed Walking
45. Corrigendum to “Elevated amyloid beta peptides and total tau in cerebrospinal fluid in individuals with Creatine transporter deficiency”
46. The contribution of platelets to peripheral BDNF elevation in children with autism spectrum disorder
47. Intelligence Quotient
48. Standardized Behavior Checklists
49. Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression
50. Disentangling the association of depression on the anti-fatigue effects of ketamine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.